|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Cerebrovascular Disorder | |||||
| Epilepsy | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Cerebrovascular Disorders | |||||
| 3 | More general conditions related to this trial | ||||
| Brain Diseases | |||||
| Cardiovascular Diseases | |||||
| Central Nervous System Diseases | |||||
| Nervous System Diseases | |||||
| Vascular Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| 15 O Water | |||||
| FDG | |||||
| 5 | Sponsors listed in this trial | ||||
| National Institute of Neurological Disorders and Stroke (NINDS) | |||||